Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation. Journal of the European Academy of Dermatology and Venereology, 33(11).
Nos publications
Depuis sa création, l’Institut Roche a mis son expertise au profit de nombreuses publications scientifiques.
Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma. Translational oncology, 13(2), 275–286.
Reger de Moura, C., Vercellino, L., Jouenne, F., Baroudjian, B., Sadoux, A., Louveau, B., Delyon, J., Serror, K., Goldwirt, L., Merlet, P., Bouquet, F., Battistella, M., Lebbé, C., & Mourah, S. (2020).
https://doi.org/10.1016/j.tranon.2019.10.003A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma. Frontiers in Immunology, 10.
Decaup, E., Rossi, C., Gravelle, P., Laurent, C., Bordenave, J., Tosolini, M., Tourette, A., Perrial, E., Dumontet, C., Poupot, M., Klein, C., Savina, A., Fournié, J. J., & Bezombes, C. (2019).
https://doi.org/10.3389/fimmu.2019.01943Social Anxiety in Children and Adolescents With Autism Spectrum Disorders Contribute to Impairments in Social Communication and Social Motivation. Frontiers in Psychiatry, 11.
Briot, K., Jean, F., Jouni, A., Geoffray, M. M., Ly-Le Moal, M., Umbricht, D., Chatham, C., Murtagh, L., Delorme, R., Bouvard, M., Leboyer, M., & Amestoy, A. (2020).
https://doi.org/10.3389/fpsyt.2020.00710Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders : stigma/consequence of unresolved early infectious events ? Molecular Autism, 10(1).
Bennabi, M., Tarantino, N., Gaman, A., Scheid, I., Krishnamoorthy, R., Debré, P., Bouleau, A., Caralp, M., Gueguen, S., Le-Moal, M. L., Bouvard, M., Amestoy, A., Delorme, R., Leboyer, M., Tamouza, R., & Vieillard, V. (2019).
https://doi.org/10.1186/s13229-019-0269-1Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function. Frontiers in Immunology, 10.
Degos, C., Heinemann, M., Barrou, J., Boucherit, N., Lambaudie, E., Savina, A., Gorvel, L., & Olive, D. (2019).
https://doi.org/10.3389/fimmu.2019.00877Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells. Cancers, 11(3), 291.
Latour, S., Zanese, M., le Morvan, V., Vacher, A. M., Menard, N., Bijou, F., Durrieu, F., Soubeyran, P., Savina, A., Vacher, P., & Bresson-Bepoldin, L. (2019).
https://doi.org/10.3390/cancers11030291La médecine de précision en oncologie : challenges, enjeux et nouveaux paradigmes. Bulletin du Cancer, 106(2), 97-104.
Cox, S., Rousseau-Tsangaris, M., Abou-Zeid, N., Dalle, S., Leurent, P., Cutivet, A., Le, H. H., Kotb, S., Bogaert, B., Gardette, R., Baran, Y., Holder, J. M., Lerner, L., Blay, J. Y., Cambrosio, A., Tredan, O., & Denèfle, P. (2019).
https://doi.org/10.1016/j.bulcan.2019.01.007Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5. Theranostics, 9(4), 1181-1199.